Back to Search Start Over

Potential benefits of anticoagulant doses of low molecular weight heparin in COVID-19: An observational retrospective study

Authors :
E. Fabrizi
P. Novara
Luca Rosato
Gianluca Lanati
M. G. Coccia
M. Di Dio
Paola Rucci
C. Franco
G. Leddi
M. Stabile
D. Aschieri
Gloria Taliani
C. Maestri
G. Bisceglie
Source :
Emergency Care Journal, Vol 17, Iss 3 (2021)
Publication Year :
2021
Publisher :
PAGEPress Publications, 2021.

Abstract

Hypercoagulability is a common complication of the systemic inflammation related to coronavirus disease 2019 creating debate within the critical care community on the therapeutic utility of Low Molecular Weight Heparin (LMWH). We collected data on consecutive patients with COVID-19 admitted to the Emergency Department of Castel San Giovanni Hospital, between February 29th and April 7th, 2020. Exclusion criteria were age

Details

ISSN :
22822054 and 18269826
Volume :
17
Database :
OpenAIRE
Journal :
Emergency Care Journal
Accession number :
edsair.doi.dedup.....cb5e6eb5900e860f644ce1904d2e466f
Full Text :
https://doi.org/10.4081/ecj.2021.9795